| 8.52 0.26 (3.15%) | 04-17 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10 |
1-year : | 11.69 |
| Resists | First : | 8.56 |
Second : | 10 |
| Pivot price | 7.98 |
|||
| Supports | First : | 7.76 |
Second : | 7.26 |
| MAs | MA(5) : | 8.3 |
MA(20) : | 7.9 |
| MA(100) : | 10.03  |
MA(250) : | 11.83 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 89.1 |
D(3) : | 84 |
| RSI | RSI(14): 59.7 |
|||
| 52-week | High : | 16.17 | Low : | 7.26 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ AVTR ] has closed below upper band by 2.4%. Bollinger Bands are 29.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.58 - 8.61 | 8.61 - 8.64 |
| Low: | 8.22 - 8.26 | 8.26 - 8.3 |
| Close: | 8.45 - 8.52 | 8.52 - 8.58 |
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, clinical, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Avantor, Inc. was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Sun, 19 Apr 2026
Analysts hold neutral stance on Avantor, Inc. (AVTR) amid lower valuation expectations - MSN
Sun, 19 Apr 2026
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Wed, 15 Apr 2026
Avantor, Inc. (NYSE:AVTR) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Tue, 14 Apr 2026
Avantor Stock Up as New Lab Capabilities Improve Biopharma Support - TradingView
Tue, 14 Apr 2026
Avantor, Inc. $AVTR Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Mon, 13 Apr 2026
Avantor® Enhances U.S. Biomanufacturing Infrastructure with Expanded Stability and Microbial Testing Facility - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 676 (M) |
| Shares Float | 664 (M) |
| Held by Insiders | 1.4 (%) |
| Held by Institutions | 103.2 (%) |
| Shares Short | 38,570 (K) |
| Shares Short P.Month | 39,870 (K) |
| EPS | -0.78 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.23 |
| Profit Margin | -8.1 % |
| Operating Margin | 10.1 % |
| Return on Assets (ttm) | 2.9 % |
| Return on Equity (ttm) | -9.2 % |
| Qtrly Rev. Growth | -1.4 % |
| Gross Profit (p.s.) | 3.16 |
| Sales Per Share | 9.68 |
| EBITDA (p.s.) | 1.44 |
| Qtrly Earnings Growth | -89.5 % |
| Operating Cash Flow | 624 (M) |
| Levered Free Cash Flow | 508 (M) |
| PE Ratio | -10.93 |
| PEG Ratio | 0 |
| Price to Book value | 1.03 |
| Price to Sales | 0.87 |
| Price to Cash Flow | 9.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|